These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7648857)

  • 1. Declining services for the chemically dependent.
    Blansfield HN
    Conn Med; 1995 Jun; 59(6):369-70. PubMed ID: 7648857
    [No Abstract]   [Full Text] [Related]  

  • 2. Financing and payment reform for primary health care and substance abuse treatment.
    Kunnes R; Niven R; Gustafson T; Brooks N; Levin SM; Edmunds M; Trumble JG; Coye MJ
    J Addict Dis; 1993; 12(2):23-42. PubMed ID: 8386551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How many people need substance abuse treatment in North Carolina and how much does it cost?
    McCarthy P; Kissling G; Dirkers J
    N C Med J; 1993 May; 54(5):209-12. PubMed ID: 8389988
    [No Abstract]   [Full Text] [Related]  

  • 4. Unit cost of counseling and patients length of stay in a residential drug treatment setting.
    Alemi F; Haack M; Holifield L; Claudio Y; Haqqi K
    J Ment Health Policy Econ; 2002 Sep; 5(3):103-7. PubMed ID: 12728196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical care utilization as a function of recovery status following chemical addictions treatment.
    Hoffmann NG; DeHart SS; Fulkerson JA
    J Addict Dis; 1993; 12(1):97-108. PubMed ID: 8381031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Our employers should pay for care at treatment center. Interview by Elisabet Forslind].
    Hallmer-Lindahl E
    Vardfacket; 1990 Aug; 14(13):17-8. PubMed ID: 1965464
    [No Abstract]   [Full Text] [Related]  

  • 7. The business of addiction treatment: A research agenda.
    Kimberly JR; McLellan AT
    J Subst Abuse Treat; 2006 Oct; 31(3):213-9. PubMed ID: 16996384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of health economics in substance abuse research. Recent advances and future opportunities. Overview.
    French MT
    Recent Dev Alcohol; 2001; 15():201-8. PubMed ID: 11449742
    [No Abstract]   [Full Text] [Related]  

  • 10. Rehab centers run dry.
    Gleick E
    Time; 1996 Feb; 147(6):44-5. PubMed ID: 10172560
    [No Abstract]   [Full Text] [Related]  

  • 11. Medicaid reimbursement of primary care providers for treatment of substance use disorders.
    Haack MR; Alemi FF
    Subst Abus; 2002 Sep; 23(3 Suppl):95-104. PubMed ID: 23580989
    [No Abstract]   [Full Text] [Related]  

  • 12. Substance abuse treatment for Ontario residents in the United States.
    Rush B; Tyas S; Martin G
    Addiction; 1996 May; 91(5):671-85. PubMed ID: 8935252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Women and children last. Barriers to drug treatment for women.
    Brown L
    Health PAC Bull; 1992; 22(2):15-9. PubMed ID: 10171224
    [No Abstract]   [Full Text] [Related]  

  • 14. Modest 5 percent increase in federal funding of ADAMHA programs approved by Congress for 1992.
    Hosp Community Psychiatry; 1992 Feb; 43(2):190-1. PubMed ID: 1572624
    [No Abstract]   [Full Text] [Related]  

  • 15. Substance abuse treatment evolves: a follow-up.
    Spath P
    Hosp Peer Rev; 1997 Sep; 22(9):132-4. PubMed ID: 10173140
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost-effectiveness of alcohol and drug treatment programs.
    Caldwel JR
    J Fla Med Assoc; 1993 Jun; 80(6):385-6. PubMed ID: 8340771
    [No Abstract]   [Full Text] [Related]  

  • 17. Detoxification centers: who's in the revolving door?
    McCarty D; Caspi Y; Panas L; Krakow M; Mulligan DH
    J Behav Health Serv Res; 2000 Aug; 27(3):245-56. PubMed ID: 10932439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health economics of addiction.
    Salize HJ; Mohler-Kuo M; Godfrey C; Holder H
    Alcohol Clin Exp Res; 2005 Jul; 29(7):1288-91. PubMed ID: 16088986
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost and usage impacts of treatment initiation: a comparison of alcoholism and drug abuse treatments.
    Goodman AC; Nishiura E; Humphreys RS
    Alcohol Clin Exp Res; 1997 Aug; 21(5):931-8. PubMed ID: 9267547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A discrete choice model of drug abuse treatment location.
    Goodman AC; Nishiura E; Hankin JR
    Health Serv Res; 1998 Apr; 33(1):125-45. PubMed ID: 9566181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.